The approval was based on data from the ProDERM study, which evaluated the efficacy and safety of Octagam 10% in 95 adults with dermatomyositis.
Researchers presented a study protocol for a trial evaluating the efficacy of 3 forms of virtual reality interventions for patients with highly prevalent chronic lower back pain.
The researchers studied mothers of infants with neonatal abstinence syndrome and/or prenatal substance exposure and whether they received treatment for substance use disorder.
New coronavirus infections are once again climbing in the United States, driven by the highly contagious Delta variant, lingering vaccine resistance, and Fourth of July celebrations.
Asking people about a history of psoriasis may be useful for assessing psoriasis prevalence, but a similar questionnaire assessing atopic dermatitis does not appear to be as reliable of a method.
The prevalence of medication use for treatment of opioid use disorder (OUD) increased from 2014 through 2018 among US Medicaid enrollees in 11 states.
COVID-19 vaccine makers such as Pfizer should focus on getting shots to poor countries instead of trying to persuade wealthy nations to give their citizens booster shots, World Health Organization officials said at a press briefing held Monday.
Study reveals that almost 90% of men have hypogonadism at the time of hospital admission for COVID-19.
Clinicians writing about the rising rates of suicide and suicidal behaviors among Black youth address the lack of suitable available data and call for the need to mobilize research for prevention.
Messenger RNA (mRNA) from COVID-19 vaccines is not detectable in breast milk.